Topoisomerase

Shop By

Items 51-70 of 70

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. DNA Topoisomerase I inhibitor

    CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types.
  2. DNA topoisomerase I inhibitor

    MAC glucuronide phenol-linked SN-38 is a pH-susceptible lactone MAC glucuronide phenol-linked SN-38 (DNA topoisomerase I inhibitor) drug linker. MAC glucuronide phenol-linked SN-38 is cytotoxic across L540cy cells and Ramos cells with IC50 values of 113 and 67 ng/mL, respectively.
  3. Topoisomerase I inhibitor

    MAC glucuronide α-hydroxy lactone-linked SN-38 (Topoisomerase I inhibitor) is a stabilized lactone MAC glucuronide α-hydroxy lactone-linked SN-38 drug linker.
  4. DNA topoisomerase I inhibitor

    CL2-SN-38 is a part of the antibody drug conjugate (ADC), can conjugate with the anti-Trop-2-humanized antibody hRS7. SN-38 is a DNA topoisomerase I inhibitor.
  5. DNA topoisomerase I/II inhibitor

    Intoplicine is a DNA topoisomerase I and II inhibitor.
  6. Top1 inhibitor

    Indotecan (LMP-400) is a potent topoisomerase 1(Top1) inhibitor with IC50 values of 300, 1200, 560 nM for P388, HCT116, MCF-7 cell lines, respectively.
  7. topoisomerase II inhibitor

    Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.
  8. topoisomerase I inhibitor

    Namitecan is a potent topoisomerase I inhibitor, with antitumor property.
  9. topoisomerase I inhibitor

    Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.
  10. Topoisomerase I inhibitor

    Edotecarin is a potent inhibitor of topoisomerase I that can induces single-strand DNA cleavage, with IC50 of 50 nM.
  11. gyrase B inhibitor

    VXc-486 is a gyrase B inhibitor, with bactericidal activity.
  12. DNA topoisomerase I inhibitor

    Exatecan Mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
  13. DNA topoisomerase I inhibitor

    Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
  14. prodrug of the topoisomerase inhibitor Daunorubicin

    Daun02 is a prodrug of the topoisomerase inhibitor Daunorubicin.
  15. Topoisomerase inhibitor

    Zabofloxacin hydrochloride (DW-224a) is a novel fluoronaphthyridone quinolone that is considered a potent antibacterial candidate for clinical trials.
  16. topoisomerase II inhibitor

    Daunorubicin (Daunomycin; RP 13057; Rubidomycin) is a topoisomerase II inhibitor with potent antineoplastic activities.
  17. DNA topoisomerase I/II inhibitor

    TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.
  18. DNA gyrase/topoisomerase inhibitor

    Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor.
  19. topoisomerase I inhibitor

    Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells.
  20. topoisomerase I inhibitor

    Topovale, also known as ARC-111, is a potent topoisomerase I inhibitor.

Items 51-70 of 70

Page
per page
Set Descending Direction